Table 2 Mean Throughput time (workdays) in post measurement
After 3 months | After 3–6 months | ||||||
|---|---|---|---|---|---|---|---|
Objective for 95% | Number of patients | Mean access time (workdays) | Mean throughput time (workdays) | Number of patients | Mean access time (workdays) | Mean throughput time (workdays) | |
Colon/Rectum cancer suspicion | 3 | 7 | 8 | 3 | 7 | 6,7 | 3 |
Colon/Rectum known cancer | 1 | 34 | 7,4 | 1 | 33 | 7,2 | 1 |
Cervix | 7 | 7 | 6,5 | 4,3 | 4 | 10,8 | 4,5 |
Ovary | 7 | 13 | 10,5 | 5 | 5 | 13 | 4,3 |
Breast | 1 | 244 | 5,3 | 1* | 247 | 5,1 | 1* |
Head and Neck | 11 | 77 | 7 | 7,6 | 56 | 7,7 | 9,5 |
Liver | 1 | 19 | 7,6 | 1,2 | 29 | 7,8 | 1 |
Esophagus/stomach | 1 | 11 | 7,7 | 1 | 30 | 7,3 | 1,3 |
Kidney | 1 | 32 | 12,4 | 1 | 32 | 7,8 | 1 |
Bladder | 6 | 42 | 10,6 | 6 | 49 | 9,2 | 5,3 |
Prostate | 1 to 6$ | 132 | 12,7 | 4,5 | 135 | 16,2^ | 4 |
Sarcoma | 7 | 45 | 8,7 | 11 | 40 | 8,8 | 11,6 |
Suspicious skin spot | 6 | 16 | 11,3 | 6 | 12 | 7,8 | 6,5 |
Total | 679 | 8,2 | 3,4 | 679 | 8,7 | 3,3 | |